Filed: 2/13/2026ACC: 0000904454-26-000111
📋 What this filing means
JOHNSON & JOHNSON filed this quarterly 13F‑HR report disclosing 17 equity positions with a total reported market value of $554.63M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
17
Positions
$554.63M
Total AUM (reported)
33.88M
Total Shares
Allocation by class
COM$381.67M68.8%
SPONSORED ADS$147.73M26.6%
CL A$22.62M4.1%
COM NEW$2.16M0.4%
ORD SHS$444.8K0.1%
Portfolio Concentration
Top 3$398.08M71.8%
4–10$147.74M26.6%
11–25$8.81M1.6%
Top 3 weight
71.8%
Top 10 weight
98.4%
Voting Authority Distribution
Total shares with voting rights: 33.88M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
33.88M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other17
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings17
Rows:
Protagonist Therapeutics Inc.
DFNDShares2.45M
TypeSH
Market value$213.91M
38.57%
Sole
0.00
Shared
2.45M
None
0.00
Nanobiotix S.A.
DFNDShares5.62M
TypeSH
Market value$130.02M
23.44%
Sole
0.00
Shared
5.62M
None
0.00
Rapport Therapeutics, Inc.
DFNDShares1.78M
TypeSH
Market value$54.14M
9.76%
Sole
0.00
Shared
1.78M
None
0.00
MeiraGTx Holdings plc
DFNDShares6.64M
TypeSH
Market value$52.80M
9.52%
Sole
0.00
Shared
6.64M
None
0.00
CVRx, Inc.
DFNDShares4.02M
TypeSH
Market value$28.58M
5.15%
Sole
0.00
Shared
4.02M
None
0.00
Contineum Therapeutics Inc.
DFNDShares1.98M
TypeSH
Market value$22.62M
4.08%
Sole
0.00
Shared
1.98M
None
0.00
Legend Biotech Corporation
DFNDShares814.59K
TypeSH
Market value$17.71M
3.19%
Sole
0.00
Shared
814.59K
None
0.00
Xencor, Inc.
DFNDShares748.06K
TypeSH
Market value$11.45M
2.06%
Sole
0.00
Shared
748.06K
None
0.00
Procept BioRobotics Corporation
DFNDShares357.94K
TypeSH
Market value$11.26M
2.03%
Sole
0.00
Shared
357.94K
None
0.00
Fate Therapeutics, Inc.
DFNDShares3.38M
TypeSH
Market value$3.32M
0.60%
Sole
0.00
Shared
3.38M
None
0.00
Neumora Therapeutics, Inc.
DFNDShares1.85M
TypeSH
Market value$3.31M
0.60%
Sole
0.00
Shared
1.85M
None
0.00
Rallybio Corporation
DFNDShares3.64M
TypeSH
Market value$2.49M
0.45%
Sole
0.00
Shared
3.64M
None
0.00
Lyell Immunopharma, Inc.
DFNDShares41.16K
TypeSH
Market value$1.27M
0.23%
Sole
0.00
Shared
41.16K
None
0.00
Vor Biopharma, Inc.
DFNDShares53.73K
TypeSH
Market value$702.8K
0.13%
Sole
0.00
Shared
53.73K
None
0.00
Nano-X Imaging Ltd.
DFNDShares158.85K
TypeSH
Market value$444.8K
0.08%
Sole
0.00
Shared
158.85K
None
0.00
Standard BioTools, Inc.
DFNDShares311.97K
TypeSH
Market value$399.3K
0.07%
Sole
0.00
Shared
311.97K
None
0.00
Adicet Bio, Inc.
DFNDShares22.78K
TypeSH
Market value$191.8K
0.03%
Sole
0.00
Shared
22.78K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Protagonist Therapeutics Inc.DFND | COM | 2.45M | SH | $213.91M 38.57% | 0.00 | 2.45M | 0.00 |
Nanobiotix S.A.DFND | SPONSORED ADS | 5.62M | SH | $130.02M 23.44% | 0.00 | 5.62M | 0.00 |
Rapport Therapeutics, Inc.DFND | COM | 1.78M | SH | $54.14M 9.76% | 0.00 | 1.78M | 0.00 |
MeiraGTx Holdings plcDFND | COM | 6.64M | SH | $52.80M 9.52% | 0.00 | 6.64M | 0.00 |
CVRx, Inc.DFND | COM | 4.02M | SH | $28.58M 5.15% | 0.00 | 4.02M | 0.00 |
Contineum Therapeutics Inc.DFND | CL A | 1.98M | SH | $22.62M 4.08% | 0.00 | 1.98M | 0.00 |
Legend Biotech CorporationDFND | SPONSORED ADS | 814.59K | SH | $17.71M 3.19% | 0.00 | 814.59K | 0.00 |
Xencor, Inc.DFND | COM | 748.06K | SH | $11.45M 2.06% | 0.00 | 748.06K | 0.00 |
Procept BioRobotics CorporationDFND | COM | 357.94K | SH | $11.26M 2.03% | 0.00 | 357.94K | 0.00 |
Fate Therapeutics, Inc.DFND | COM | 3.38M | SH | $3.32M 0.60% | 0.00 | 3.38M | 0.00 |
Neumora Therapeutics, Inc.DFND | COM | 1.85M | SH | $3.31M 0.60% | 0.00 | 1.85M | 0.00 |
Rallybio CorporationDFND | COM | 3.64M | SH | $2.49M 0.45% | 0.00 | 3.64M | 0.00 |
Lyell Immunopharma, Inc.DFND | COM NEW | 41.16K | SH | $1.27M 0.23% | 0.00 | 41.16K | 0.00 |
Vor Biopharma, Inc.DFND | COM NEW | 53.73K | SH | $702.8K 0.13% | 0.00 | 53.73K | 0.00 |
Nano-X Imaging Ltd.DFND | ORD SHS | 158.85K | SH | $444.8K 0.08% | 0.00 | 158.85K | 0.00 |
Standard BioTools, Inc.DFND | COM | 311.97K | SH | $399.3K 0.07% | 0.00 | 311.97K | 0.00 |
Adicet Bio, Inc.DFND | COM NEW | 22.78K | SH | $191.8K 0.03% | 0.00 | 22.78K | 0.00 |